Evidence map›Paper›PMID 40018038›Full record

ArticleFrontiers in immunology2025

Designing a potent multivalent epitope vaccine candidate against

Subhasmita Panda, Subrat Kumar Swain, Basanta Pravas Sahu, Soumya Ranjan Mahapatra, Jyotirmayee Dey, Rachita Sarangi, Anu Vinod Ranade, Namrata Mishra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Subhasmita PandaInstitute of Medical Sciences and SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, India.
Subrat Kumar SwainInstitute of Medical Sciences and SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, India.
Basanta Pravas SahuSchool of Biological Sciences, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Soumya Ranjan MahapatraSchool of Biotechnology, Kalinga Institute of Information and Technology (KIIT) University, Bhubaneswar, India.
Jyotirmayee DeySchool of Biotechnology, Kalinga Institute of Information and Technology (KIIT) University, Bhubaneswar, India.
Rachita SarangiInstitute of Medical Sciences and SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, India.
Anu Vinod RanadeDepartment of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Namrata MishraSchool of Biotechnology, Kalinga Institute of Information and Technology (KIIT) University, Bhubaneswar, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scrub typhus is a life-threatening, undifferentiated febrile illness caused by a gram-negative bacterium,

Indexed as

Bacterial VaccinesEpitopes, B-LymphocyteEpitopes, T-LymphocyteOrientia tsutsugamushiScrub TyphusAntigens, BacterialComputational BiologyEpitopesHumansMolecular Docking SimulationMolecular Dynamics SimulationToll-Like Receptor 2Vaccines, SubunitVaccinologyAntigens, BacterialBacterial VaccinesEpitopesEpitopes, B-LymphocyteEpitopes, T-LymphocyteToll-Like Receptor 2Vaccines, Subunitimmune simulationin-silico cloningmolecular dynamic simulationmultiplex vaccinologyprotein-protein dockingscrub typhus

Identifiers

PMID40018038
PMCPMC11865050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.